Company Overview of Triton BioSystems, Inc.
As of June 2, 2008, Triton BioSystems, Inc. was acquired by Oncologic, Inc. Triton BioSystems, Inc. engages in the discovery and development of non-invasive therapeutics to treat cancer. Its product includes Targeted Nano-Therapeutics system, which is in pre-clinical stage for the treatment of late-stage cancers, such as breast, head and neck, lung, colon, ovarian, pancreatic, and prostate. Triton BioSystems was formerly known as TriBond, Inc. The company was founded in 2001 and is based in Chelmsford, Massachusetts. Triton BioSystems, Inc. is a prior subsidiary of Triton Systems, Inc.
200 Turnpike Road
Chelmsford, MA 01824
Founded in 2001
Key Executives for Triton BioSystems, Inc.
Triton BioSystems, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|UCB Holdings, Inc.||United States|
|Merck Sharp & Dohme Corp.||United States|
|Washburn Therapeutics, Inc.||United States|
|Madeira Therapeutics LLC||United States|
|Dainippon Sumitomo Pharma America Holdings, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Triton BioSystems, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.